GAP Ventures makes a practical assessment of the current stage of technology development and your company’s short and long term capital requirements to identify the most likely funding sources. Depending upon these factors, funding sources can include one or more of:
Angel Investors. High net worth individuals or families who provide capital to early stage companies. The U.S. has well developed group and networks of angel investors that share research and pool their investment capital.
Venture Capital Funds. VC funds typically invest after the seed funding round as the first round of institutional capital to fund growth (also referred to as Series A round) in the interest of generating a return through a liquidity event, such as an IPO or trade sale of the company.
Non-dilutive Capital. Federal and state programs and incentives for small biotech companies and grants from nonprofit and venture philanthropy foundations are an important source of early stage capital. Our grant writers identify programs that meet your objectives and author scientifically cohesive applications to fit specific program requirements.
Risk-sharing Alliances. Contract manufacturers and clinical research organizations, with the infrastructure and know-how to deliver key milestones, reduce fees in exchange for equity partners and stakeholders in product development.
We leverage our extensive professional network and introduce clients to private investors, venture funds, and potential business partners and facilitate meetings, discussions and negotiations. We focus on making the right connections for our clients by matching the investment criteria and commercial interests of the parties with vetted technology opportunities.